Skip to main content

Arthritis Research & Therapy

Ausgabe Sonderheft 2/2003

1st Workshop of the International Society for Behçet's Disease (ISBD) on Pathophysiology and Treatment of Behçet's Disease

Inhalt (13 Artikel)

Meeting abstract

Introduction

CG Barnes

Meeting abstract

Cytotoxic drugs in ocular lesions of Behçet's disease

F Davatchi, F Shahram, H Chams, A Nadji, AR Jamshidi, C Chams, M Akbarian, F Gharibdoost, M Sedigh, B Sadeghi

Meeting abstract

The use of interferon-alfa in Behçet's disease: review of the literature

I Kötter, I Günaydin, M Zierhut, N Stübiger

Meeting abstract

Efficacy of recombinant human interferon-alfa2a on ocular and extra-ocular manifestations of Behçet's disease and influence on cells of the immune system: results of an open four center trial

I Kötter, M Treusch, R Vonthein, M Zierhut, A Eckstein, T Ness, I Günaydin, B Grimbacher, S Blaschke, HH Peter, N Stübiger

Meeting abstract

TNF and anti-TNF agents in Behçet's disease

KT Calamia

Meeting abstract

Migration of dendritic cells into the lymphatics: the Langerhans cell example

N Romani, P Stoitzner, S Ebner, H Stössel, S Holzmann, G Ratzinger, P Fritsch

Meeting abstract

Viral infection of retinal pigment epithelium: a possible role for initiation of Behçet's disease

EU Irschick, HP Huemer, C Larcher, R Sgonc, W Göttinger

Meeting abstract

Immunosuppressive effects of gemcitabine in the HSV-induced Behçet's disease like mouse model

S Sohn, M Lutz, HJ Kwon, G Konwalinka, S Lee, M Schirmer

Meeting abstract

Streptococcal antigen in the pathogenesis of Behçet's disease

F Kaneko, H Yanagihori, M Tojo, E Isogai, SN Lin, K Oguma

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.